These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 2508215)

  • 1. [Monoclonal gammopathies of undetermined significance called "MGUS"].
    Clément F
    Schweiz Med Wochenschr; 1989 Jul; 119(27-28):970-8. PubMed ID: 2508215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P; Merlin L; Thomas C; Piette F
    Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Rajkumar SV
    Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of monoclonal gammopathies of undetermined significance.
    Vogt RF; Marti GE
    Br J Haematol; 2007 Dec; 139(5):687-9. PubMed ID: 18021082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical practice. Monoclonal gammopathy of undetermined significance.
    Bladé J
    N Engl J Med; 2006 Dec; 355(26):2765-70. PubMed ID: 17192542
    [No Abstract]   [Full Text] [Related]  

  • 6. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
    Kelly JJ
    Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of lymphocyte subpopulations in multiple myeloma and monoclonal gammopathies of undetermined significance].
    Luraschi A; Fedeli P; Rossi M; Montanara S; Perlasca S; Cozzi S
    Minerva Med; 1986 Jun; 77(26):1235-41. PubMed ID: 3088491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurologic manifestations of monoclonal gammapathies].
    Uldry PA; Steck AJ; Regli F
    Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences in the diagnosis and treatment of polyneuropathies in patients with malignant monoclonal gammopathy].
    Baumann I; Krause T; Schwenke H; Lehmann J
    Psychiatr Neurol Med Psychol (Leipz); 1990 Feb; 42(2):85-95. PubMed ID: 2158116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA; Rajkumar SV
    Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benign monoclonal gammopathy].
    Shirota T; Kondo M; Uchida H; Ito H
    Nihon Rinsho; 1995 Mar; 53(3):720-4. PubMed ID: 7699912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.
    McMaster ML; Caporaso N
    Br J Haematol; 2007 Dec; 139(5):663-71. PubMed ID: 18021080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal gammopathies of undetermined significance].
    Hofmann V
    Schweiz Med Wochenschr; 1982 Nov; 112(48):1718-23. PubMed ID: 6817412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of monoclonal gammopathy of undetermined significance: a single-centre study.
    Simon Z; Sipka S; Gergely L; Csípö I; Illés A
    Clin Lab Haematol; 2006 Jun; 28(3):164-9. PubMed ID: 16706932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).
    Bird J; Behrens J; Westin J; Turesson I; Drayson M; Beetham R; D'Sa S; Soutar R; Waage A; Gulbrandsen N; Gregersen H; Low E;
    Br J Haematol; 2009 Oct; 147(1):22-42. PubMed ID: 19673884
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monoclonal gammopathy of undetermined significance (MGUS) in Mexican mestizos: one institution's experience].
    Ruiz-Delgado GJ; Gómez Rangel JD
    Gac Med Mex; 2004; 140(4):375-9. PubMed ID: 15456147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.
    Baldini L; Goldaniga M; Guffanti A; Broglia C; Cortelazzo S; Rossi A; Morra E; Colombi M; Callea V; Pogliani E; Ilariucci F; Luminari S; Morel P; Merlini G; Gobbi P
    J Clin Oncol; 2005 Jul; 23(21):4662-8. PubMed ID: 16034042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S; Kyle RA; Dyck PJ
    Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.